Article Text

PDF

114 N-acetyl-l-cysteine (NAC) controls osteoclastogenesis through regulating th17 differentiation and rankl production in rheumatoid arthritis
  1. HR Kim1,
  2. BM Kim2,
  3. KA Lee1,
  4. SH Lee1 and
  5. KW Kim2
  1. 1Konkuk University Hospital, Rheumatology, Seoul, Republic of Korea
  2. 2Seoul St. Mary’s Hospital- College of Medicine- The Catholic University, Convergent Research Consortium for Immunologic disease, Seoul, Republic of Korea

Abstract

Background and aims This study aimed to determine the regulatory role of N-Acetyl-l-cysteine (NAC), an antioxidant, in IL-17-induced osteoclast differentiation in rheumatoid arthritis (RA).

Methods After RA synovial fibroblasts were stimulated by IL-17, the expression and production of RANKL was determined by real-time PCR and ELISA. Human peripheral blood monocytes were cultured with M-CSF, IL-17, RANKL, and/or various concentrations of NAC, followed by counting of the cells for tartrate-resistant acid phosphatase activity to determine osteoclast formation. Osteoclastogenesis was also determined after cocultures of IL-17-stimulated RA synovial fibroblasts, Th17 cells and various concentrations of NAC with monocytes. After human peripheral CD4+ T cells were cultured with NAC under Th17 condition, IL-17, IFN-g, IL-4, Foxp3, RANKL and IL-2 expression and production was determined by flow cytometry or ELISA.

Results When RA synovial fibroblasts were stimulated by IL-17, IL-17 stimulated the production of RANKL, and NAC reduced the IL-17-induced RANKL production in a dose-dependent manner. NAC decreased IL-17-activated phosphorylation of mTOR, JNK and IkB. When human peripheral blood CD14+ monocytes were cultured with M-CSF and IL-17 or RANKL, osteoclasts were differentiated, and NAC reduced the osteoclastogenesis. After human peripheral CD4+ T cells were co-cultured with IL-17-pretreated RA synovial fibroblasts or Th17 cells, NAC reduced their osteoclastogenesis. Under Th17 polarising condition, NAC decreased Th17 cell differentiation and IL-17 and RANKL production.

Conclusions NAC inhibits the IL-17-induced RANKL production in RA synovial fibroblasts and IL-17-induced osteoclast differentiation. NAC also reduced Th17 polarisation. NAC could be a supplementary therapeutic option for inflammatory and bony destructive processes in RA.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.